Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. [electronic resource]
Producer: 20081201Description: 1241-8 p. digitalISSN:- 1534-6080
- Adolescent
- Adrenal Cortex Hormones -- therapeutic use
- Antibodies, Monoclonal -- adverse effects
- Basiliximab
- Biopsy
- Child
- Child, Preschool
- Cyclosporine -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Endpoint Determination
- Female
- Graft Rejection -- prevention & control
- Humans
- Immunosuppressive Agents -- adverse effects
- Infant
- Kaplan-Meier Estimate
- Kidney -- pathology
- Kidney Transplantation -- immunology
- Longitudinal Studies
- Male
- Mycophenolic Acid -- analogs & derivatives
- Recombinant Fusion Proteins -- adverse effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.